Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-11

Clinical Trial Update: Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating whether adding endoscopic variceal ligation (EVL) to carvedilol improves primary prevention of esophageal variceal bleeding in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Cirrhosis, Esophageal Varices | Phase 4 | Status: RECRUITING